Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells
暂无分享,去创建一个
C. Begley | Y. Mitsuuchi | Y. Deng | M. Mckinlay | C. Benetatos | T. Haimowitz | S.C. Beck | M. Arnone | GS Kapoor | Melissa Seipel | SK Chunduru | SM Condon